Karyopharm Therapeutics Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -71,903.9% | -71,153.9% |
| FY2017 | — | -8,133.2% | -8,036.4% |
| FY2018 | — | -593.0% | -588.1% |
| FY2019 | — | -462.9% | -488.1% |
| FY2020 | — | -159.0% | -181.6% |
| FY2021 | — | -46.8% | -59.1% |
| FY2022 | — | -90.5% | -105.2% |
| FY2023 | — | -88.7% | -98.0% |
| FY2024 | — | -82.2% | -52.6% |
| FY2025 | — | -62.1% | -134.2% |